Contact us
CHECKOUT (0)

  Home > High Sensitivity ELISA > HS ELISA for Metabolism Research >

New!  ENTPD3/CD39L3/ NTPDase3 (Human) ELISA Kit (Serum, Plasma)
ENTPD3 (Human) ELISA Kit
 
Our Price: $560.00


Product Code: SK00837-06
Qty:

Description Technical Specs More Information:
 
  • ENTPD3 is a newly identified biomarker for pancreatic β cells
  • Ectonucleotidase NTPDase3
  • Sandhu B, et al. Global deletion of NTPDase3 protects against diet-induced obesity by increasing basal energy metabolism. Metabolism. 2021 May;118:154731.
  • Syed SK, et al. Ectonucleotidase NTPDase3 is abundant in pancreatic β-cells and regulates glucose-induced insulin secretion. Am J Physiol Endocrinol Metab. 2013 Nov 15;305(10):E1319-26.
  • Docherty FM, et al. ENTPD3 Marks Mature Stem Cell-Derived β-Cells Formed by Self-Aggregation In Vitro. Diabetes. 2021 Nov;70(11):2554-2567.
Feature of this ELISA Kit:
  • High Sensitivity Antibody Pair
  • Calibrator is bioactive human ENTPD3 protein (HEK293) which has glycosylated and disulfide bonds. That is different with a calibrator derived from E. Coli expressed .
  • Sample Tested.
  • Size: 96T, 2 x 96 T ($1080 per 192T)
Features
    • Sandhu B, et al. Global deletion of NTPDase3 protects against diet-induced obesity by increasing basal energy metabolism. Metabolism. 2021 May;118:154731.
    ENTPD3 (Human) ELISA KIt
    Code No.: SK00837-06
    Size: 96 T
    Price: $560 USD
    Standard range: 62.5 - 4000 pg/ml
    Sensitivity:20 pg/ml
    Specificity: human ENTPD3
    Sample Type: serum
    Dilution Factor: 20
    Sample require: 100 uL of diluted sample per well
    Intra-CV:2-5%
    Inter-CV: 4-9%
    Protocol: PDF


Browse for more products in the same category as this item:

High Sensitivity ELISA > HS ELISA for Metabolism Research
High Sensitivity ELISA > HS ELISA for Cardiovascular Research
High Sensitivity ELISA > HS ELISA for Cancer Research
High Sensitivity ELISA
ELISA > CD ELISA for Research
Copyright © 2016 Aviscera Bioscience, Inc.. All Rights Reserved. Built with Volusion.